Abstract
Postinfectious forms of encephalomyelitis, also termed acute disseminated encephalomyelitis (ADEM), form one of several categories of inflammatory demyelinating disorders of the central nervous system (CNS). Recent large, retrospective case series have refined our understanding of the clinical, laboratory, and neuroimaging characteristics of ADEM. The differences between childhood and adult ADEM, risks of development of multiple sclerosis, and the contributions of recent studies to refining the nosology of CNS demyelinating syndromes are discussed.
Similar content being viewed by others
References and Recommended Reading
Dale RC, de Sousa C, Chong WK, et al.: Acute disseminated encephalomyelitis, multiphasic encephalomyelitis and multiple sclerosis in children. Brain 2000, 123:2407–2422. Large, contemporary comparison of children with acute disseminated encephalomyelitis, multiphasic encephalomyelitis, and multiple sclerosis and mean follow-up of nearly 6 years.
Hynson JL, Kornberg AJ, Coleman LT, et al.: Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001, 56:1308–1312. Retrospective review notes some general differences at presentation between cases that eventually are diagnosed as acute disseminated encephalomyelitis and multiple sclerosis.
Murthy SN, Faden HS, Cohen ME, Bakshi R: Acute disseminated encephalomyelitis in children. Pediatrics 2002, 110:e21. This smaller series utilized more strict diagnostic criteria and provides detailed magnetic resonance imaging results.
Schwarz S, Mohr A, Knauth M, et al.: Acute disseminated encephalomyelitis. A follow-up study of 40 adult patients. Neurology 2001, 56:1313–1318. This is the largest modern series of adults presenting with acute disseminated encephalomyelitis.
Tenembaum S, Chamoles N, Fejerman N: Acute disseminated encephalomyelitis. A long-term follow-up study of 84 pediatric patients. Neurology 2002, 59:1224–1231. This large, prospective series of childhood acute disseminated encephalomyelitis provides more than 6 years of mean follow-up data and emphasizes a generally good prognosis.
Bhigjee AI, Patel VB, Bhagwan B, et al.: HIV and acute disseminated encephalomyelitis. S Afr Med J 1999, 89:283–284.
Narisco P, Galgani S, Del Grosso B, et al.: Acute disseminated encephalomyelitis as manifestation of primary HIV infection. Neurology 2001, 57:1493–1496.
Tachi N, Watanabe T, Wakai S, et al.: Acute disseminated encephalomyelitis following HTLV-1 associated myelopathy. J Neurol Sci 1992, 110:234–235.
Sacconi S, Salviati L, Merelli E: Acute disseminated encephalomyelitis associated with hepatitis C virus infection. Arch Neurol 2001, 58:1679–1681.
Spieker S, Petersen D, Rolfs A, et al.: Acute disseminated encephalomyelitis following Pontiac fever. Eur Neurol 1998, 40:169–172.
Heick A, Skriver E: Chlamydia pneumoniae-associated ADEM. Eur J Neurol 2000, 7:435–438.
Sommer JB, Erbguth FJ, Neundorfer B: Acute disseminated encephalomyelitis following Legionella pneumophila infection. Eur Neurol 2000, 44:182–184.
Dodick DW, Silber MH, Noseworthy JH, et al.: Acute disseminated encephalomyelitis after accidental injection of a hog vaccine: successful treatment with plasmapheresis. Mayo Clin Proc 1998, 73:1193–1195.
Patel SP, Friedman RS: Neuropsychiatric features of acute disseminated encephalomyelitis: a review. J Neuropsychiatr Clin Neurosci 1997, 9:534–540.
Moscovich DG, Singh MB, Eva FJ, Puri BK: Acute disseminated encephalomyelitis presenting as an acute psychotic state. J Nerv Ment Dis 1995, 183:116–117.
Wang PN, Fuh JL, Liu HC, Wang SJ: Acute disseminated encephalomyelitis in middle-aged or elderly patients. Eur Neurol 1996, 36:219–223.
Nasr JT, Andriola MR, Coyle PK: ADEM: Literature review and case report of acute psychosis presentation. Pediatr Neurol 2000, 22:8–18.
Dale RC, Church AJ, Cardoso F, et al.: Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Ann Neurol 2001, 50:588–595. The authors identify a subgroup of pediatric post-streptococcal acute disseminated encephalomyelitis with prominent extrapyramidal and behavioral signs and specific autoantibodies.
Ziegler DK: Acute disseminated encephalitis: some diagnostic and therapeutic considerations. Arch Neurol 1966, 14:476–488.
Atlas SW, Grossman RK, Goldberg HI, et al.: Diagnosis of acute disseminated encephalomyelitis. J Comput Assist Tomogr 1986, 10:798–801.
Kanter DS, Horensky D, Sperling RA, et al.: Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology 1995, 45:824–827.
Modi G, Mochan A, Modi M, Saffer D: Demyelinating disorder of the central nervous system occurring in black South Africans. J Neurol Neurosurg Psychiatry 2001, 70:500–505. These eight cases demonstrate features of neuromyelitis optica, acute disseminated encephalomyelitis, and multiple sclerosis, highlighting the challenges faced in classification of central nervous system demyelinating syndromes.
Murray BJ, Apetauerova D, Scammell TE: Severe acute disseminated encephalomyelitis with normal MRI at presentation. Neurology 2000, 55:1237–1238.
Honkaniemi J, Dastidar P, Kähärä V, Haapasalo H: Delayed MR imaging changes in acute disseminated encephalomyelitis. Am J Neuroradiol 2001, 22:1117–1124.
Baum PA, Barkovich AJ, Koch TK, Berg BO: Deep gray matter involvement in children with acute disseminated encephalomyelitis. Am J Neuroradiol 1994, 15:1275–1283.
Olivero WC, Deshmukh P, Gujrati M: Bilateral enhancing thalamic lesions in a 10 year old boy: case report. J Neurol Neurosurg Psychiatry 1999, 66:633–635.
Hamed LM, Silbiger J, Guy J, et al.: Parainfectious optic neuritis and encephalomyelitis. A report of two cases with thalamic involvment. J Clin Neuro-ophthalmol 1993, 13:18–23.
Miller DH, Scaravilli F, Thomas DC, et al.: Acute disseminated encephalomyelitis presenting as a solitary brainstem mass. J Neurol Neurosurg Psychiatry 1993, 56:920–922.
De Recondo A, Guichard JP: Acute disseminated encephalomyelitis presenting as multiple cystic lesions. J Neurol Neurosurg Psychiatry 1997, 63:15.
van der Meyden CH, de Villiers JF, Middlecote BD, Terblanchè J: Gadolinium ring enhancement and mass effect in acute disseminated encephalomyelitis. Neuroradiol 1994, 36:221–223.
Bizzi A, Ulug AM, Crawford TO, et al.: Quantitative proton MR spectroscopic imaging in acute disseminated encephalomyelitis. Am J Neuroradiol 2001, 22:1125–1130.
Harada M, Hisaoka S, Mori K, et al.: Differences in water diffusion and lactate production in two different types of postinfectious encephalopathy. J Mag Res Imag 2000, 11:559–563.
Bernarding J, Braun J, Koennecke H-C: Diffusion- and perfusion-weighted MR imaging in a patient with acute disseminated encephalomyelitis (ADEM). J Mag Res Imag 2002, 15:96–100.
Tan TX, Spigos DG, Mueller CF: Abnormal cortical metabolism in acute disseminated encephalomyelitis. Clin Nucl Med 1998, 23:629–630.
Itti E, Huff K, Cornford ME, et al.: Postinfectious encephalitis. A coregistered SPECT and magnetic resonance imaging study. Clin Nucl Med 2002, 27:129–130.
Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG: Multiple sclerosis. N Engl J Med 2000, 343:938–952.
Jacobs LD, Beck RW, Simon JH, et al.: Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 2000, 343:898–904.
Comi G, Filippi M, Barkhof F, et al.: Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001, 357:1576–1582.
O’Riordan JI, Gomez-Anson B, Moseley IF, Miller DH: Long term MRI follow-up of patients with post infectious encephalomyelitis: evidence for a monophasic disease. J Neurol Sci 1999, 167:132–136.
McDonald WI, Compston A, Edan G, et al.: Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001, 50:121–127. These new diagnostic recommendations integrate magnetic resonance imaging (MRI) findings and specifically suggest that new MRI lesions occurring after a 3-month interval following the first attack may differentiate acute disseminated encephalomyelitis from multiple sclerosis.
Miller HG, Evans MJ: Prognosis in acute disseminated encephalomyelitis; with a note on neuromyelitis optica. Q J Med 1953, 22:347–349.
Durston JH, Milnes JN: Relapsing encephalomyelitis. Brain 1970, 93:715–730.
Cohen O, Steiner-Birmanns B, Biran I, et al.: Recurrence of acute disseminated encephalomyelitis at the previously affected brain site. Arch Neurol 2001, 58:797–801.
Straub J, Chofflon M, Delavelle J: Early high-dose intravenous methylprednisolone in acute disseminated encephalomyelitis: a successful recovery. Neurology 1997, 49:1145–1147.
Weinshenker BG, O’Brien PC, Petterson TM, et al.: A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999, 46:878–886.
Rodriguez M, Karnes WE, Bartleson JD, Pineda AA: Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology 1993, 43:1100–1104.
Miyazawa R, Hikima A, Takano Y, et al.: Plasmapheresis in fulminant acute disseminated encephalomyelitis. Brain Dev 2001, 23:424–426.
Kleiman M, Brunquell P: Acute disseminated encephalomyelitis: response to intravenous immunoglobulin? J Child Neurol 1995, 10:481–483.
Hahn JS, Siegler DJ, Enzmann D: Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis. Neurology 1996, 46:1173–1174.
Pradhan S, Gupta RP, Shashank S, Pandey N: Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. J Neurol Sci 1999, 165:56–61.
Sahlas DJ, Miller SP, Guerin M, et al.: Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology 2000, 54:1370–1372.
Marchioni E, Marinou-Aktipi K, Uggetti C, et al.: Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol 2002, 249:100–104.
Takata T, Hirakawa M, Sakurai M, Kanazawa I: Fulminant form of acute disseminated encephalomyelitis: successful treatment with hypothermia. J Neurol Sci 1999, 165:94–97.
Gold R, Hartung H-P, Toyka KV: Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today 2000, 6:88–91.
Ben-Nun A, Wekerle H, Cohen IR: The rapid isolation of clonable antigen specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 1981, 11:195–199.
Kuchroo VK, Sobel RA, Yamamura T, et al.: Induction of experimental allergic encephalomyelitis by myelin proteolipidprotein-specific T cell clones and synthetic peptides. Pathobiology 1991, 59:305–312.
Linington C, Engelhardt B, Kapocs G, Lassman H: Induction of persistently demyelinated lesions in the rate following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J Neuroimmunol 1992, 40:219–242.
Miller SD, Vanderlugt CL, Begolka WS, et al.: Persistent infection with Theiler’s virus leads to autoimmunity via epitope spreading. Nat Med 1997, 3:1133–1136.
Racke MK, Quigley L, Cannella B, et al.: Superantigen modulation of experimental allergic encephalomyelitis: activation of anergy determines outcome. J Immunol 1994, 152:2051–2059.
Eugster HP, Frei K, Winkler F, et al.: Superantigen overcomes resistance of IL-6-deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway. Eur J Immunol 2001, 31:2302–2312.
Jorens PG, VanderBorght A, Ceulemans B, et al.: Encephalomyelitis-associated antimyelin autoreactivity induced by streptococcal exotoxins. Neurology 2000, 54:1433–1441.
Wingerchuk DM, Lucchinetti CF, Noseworthy JH: Multiple sclerosis: current pathophysiological concepts. Lab Invest 2001, 81:263–281.
Ichiyama T, Shoji H, Kato M, et al.: Cerebrospinal fluid levels of cytokines and soluble tumour necrosis factor receptor in acute disseminated encephalomyelitis. Eur J Pediatr 2002, 161:133–137.
Bauer J, Stadelmann C, Bancher C, et al.: Apoptosis of T lymphocytes in acute disseminated encephalomyelitis. Acta Neuropathol 1999, 97:543–546.
Laouini D, Kennou MF, Khoufi S, Dellagi K: Antibodies to human myelin proteins and gangliosides in patients with acute neuroparalytic accidents induced by brain-derived rabies vaccine. J Neuroimmunol 1998, 91:63–72.
Pohl-Koppe A, Burchett SK, Thiele EA, Hafler DA: Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis. J Neuroimmunol 1998, 19–27.
Lucchinetti CF, Mandler RN, McGavern D, et al.: A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 2002, 125:1450–1461. The authors describe immunopathologic evidence for humoral immune mechanisms in neuromyelitis optica.
Transverse Myelitis Consortium Working Group: Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002, 59:499–505. This paper is an effort towards consensus and standardization in the study of acute transverse myelitis.
Mandler RN, Davis LE, Jeffery DR, Kornfeld M: Devic’s neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993, 34:162–168.
O’Riordan JI, Gallagher HL, Thompson AJ, et al.: Clinical, CSF, and MRI findings in Devic’s neuromyelitis optica. J Neurol Neurosurg Psychiatr 1996, 60:382–387.
Wingerchuk DM, Hogancamp WH, O’Brien PC, Weinshenker BG: The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 1999, 53:1107–1114.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wingerchuk, D.M. Postinfectious encephalomyelitis. Curr Neurol Neurosci Rep 3, 256–264 (2003). https://doi.org/10.1007/s11910-003-0086-x
Issue Date:
DOI: https://doi.org/10.1007/s11910-003-0086-x